Back to Search
Start Over
Long-term bevacizumab is safe and effective in managing small bowel angioectasias bleeding refractory to conventional treatments: a case report.
- Source :
-
Gastroenterology report [Gastroenterol Rep (Oxf)] 2024 Jul 06; Vol. 12, pp. goae070. Date of Electronic Publication: 2024 Jul 06 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Competing Interests: None to declare for all authors. Figure 1.Mean Hb levels during the observation period. The grey thinner box corresponds to the lower dose of bevacizumab. Hb = haemoglobin, BVZ = bevacizumab.
Details
- Language :
- English
- ISSN :
- 2052-0034
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Gastroenterology report
- Publication Type :
- Academic Journal
- Accession number :
- 38974879
- Full Text :
- https://doi.org/10.1093/gastro/goae070